The UCL Institute of Cardiovascular Science brings together basic and clinical scientists from UCL and expert clinicians from UCL partner hospitals to provide:

  • Innovative research for the prevention and treatment of diseases of the heart and circulation
  • World-class teaching and training in the Cardiovascular Sciences¬†
  • Forward-thinking policy development for effective Cardiovascular disease management

We have about 140 members of staff and 40 research students who are based in different research centres across the Bloomsbury campus and in UCL partner hospitals.

Our research is broad, spanning discovery-based laboratory science, clinical translation and experimental medicine, as well as healthcare evaluation, implementation and policy. Much of the work is interdisciplinary, integrating with UCL Engineering, Nanotechnology, Chemistry, Behavioural Science, and the UCL Genetics Institute. We have a flourishing link with leading cardiovascular scientists and clinicians at Yale University through the Yale UCL Collaborative.

Athena SWAN logo

ICS is working towards a silver Athena SWAN Award and we support the Athena beliefs that:

  • The advancement of science, engineering and technology (SET) is fundamental to quality of life across the globe.
  • It is vitally important that women are adequately represented in what has traditionally been, and is still, a male-dominated area.
  • Science cannot reach its full potential unless it can benefit from the talents of the whole population, and until women and men can benefit equally from the opportunities it affords.

Six principles represent the cornerstone of Athena SWAN:

  1. To address gender inequalities requires commitment and action from everyone, at all levels of the organisation.
  2. To tackle the unequal representation of women in science requires changing cultures and attitudes across the organisation.
  3. The absence of diversity at management and policy-making levels has broad implications which the organisation will examine.
  4. The high loss rate of women in science is an urgent concern which the organisation will address.
  5. The system of short-term contracts has particularly negative consequences for the retention and progression of women in science, which the organisation recognises.
  6. There are both personal and structural obstacles to women making the transition from PhD into a sustainable academic career in science, which require the active consideration of the organisation.
The Heart Hospital QMUL Yale Cardiometabolic domain





Find out about the work that takes place in the research centres of Great Ormond Street Hospital, Hatter Cardiovascular Institute, The Heart Hospital, The Rayne Institute, UCL Institute of Child Health, UCL Institute of Ophthalmology.

ICS researchers collaborate extensively with colleagues at the William Harvey Research Institute at Barts and The London School of Medicine and Dentistry.

Yale and UCL have entered into a unique partnership called the Yale UCL Collaborative. UCL PhD students are able to apply for the Yale exchange programme. This has been designed to provide students with the opportunity to study at Yale for a defined period of research.

The domain encompasses research into obesity, diabetes, cardiovascular risk, metabolic syndrome/insulin resistance, cardiovascular physiology and disease, vascular cell biology, microangiopathies, as well as related clinical trials.